Equities

LSL Pharma Group Inc

LSL:CVE

LSL Pharma Group Inc

Actions
  • Price (CAD)0.49
  • Today's Change0.00 / 0.00%
  • Shares traded21.00k
  • 1 Year change-10.91%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024 20:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company. The Company is specializing in the development, manufacturing and distribution of natural health products and dietary supplements in solid dosage forms, as well as sterile ophthalmic pharmaceutical products. The Company’s subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Groupe Immobilier LSL inc.

  • Revenue in CAD (TTM)10.03m
  • Net income in CAD-8.47m
  • Incorporated2010
  • Employees--
  • Location
    LSL Pharma Group Inc540, rue d'Avaugour, Office 1800BOUCHERVILLE J4B 0G6CanadaCAN
  • Phone+1 (450) 681-7744
  • Fax+1 (450) 681-8400
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medexus Pharmaceuticals Inc157.49m8.00m39.11m98.004.410.97272.450.24830.36260.36267.241.640.75472.195.441,607,042.003.83-6.838.44-9.7952.9153.905.08-11.450.70130.94260.6388--40.9369.17142.41---8.59--
Charlotte's Web Holdings Inc79.30m-41.53m39.28m164.00--0.6189--0.4954-0.2707-0.27070.51650.40390.36681.0727.08483,526.10-19.21-25.71-22.16-29.0355.8848.98-52.37-63.112.33--0.478---14.82-1.9059.88---7.88--
IntelGenx Technologies Corp.1.41m-13.51m41.92m48.00------29.65-0.0774-0.07740.0081-0.09540.118926.061.56---113.63-75.15-297.44-133.79-66.80---955.44-819.850.4001-5.995.41--9.37-10.657.14---30.32--
Immunoprecise Antibodies Ltd23.68m-14.26m42.26m102.00--0.8483--1.78-0.416-0.4160.68961.390.29395.256.76170,583.50-17.70-23.62-19.62-27.2551.8857.18-60.23-76.181.38--0.2241--6.7230.59-58.96--34.04--
Decibel Cannabis Company Inc115.96m-1.77m44.96m----0.97433.560.3878-0.0045-0.00450.27390.11290.8171.517.66---1.25-3.55-2.04-5.1936.1038.83-1.53-7.130.36851.210.5122--46.18--60.33---32.45--
Microbix Biosystems Inc23.84m4.06m45.32m69.0011.161.638.301.900.02960.02960.1730.2020.67031.676.33--11.42-0.972912.72-1.1754.3852.3017.04-1.554.983.530.1948---13.435.71-102.21---3.56--
Helix Biopharma Corp.0.00-5.65m48.15m9.00---------0.0277-0.02770.00-0.00120.00----0.00-318.95-261.49-574.76-------------2,825.00--------4.16---28.36--
MustGrow Biologics Corp4.71m-676.95k51.12m0.00--9.49--10.85-0.0144-0.01440.09440.10850.6697--51.61---9.62-50.41-11.96-59.28-----14.37-298.73----0.1197--72,619.13372.5487.84------
Satellos Bioscience Inc0.00-21.13m52.98m12.00--1.54-----0.1718-0.17180.000.30590.00----0.00-93.29-107.22-109.86-136.58------------0.00-------40.33--459.46--
LSL Pharma Group Inc10.03m-8.47m53.00m----4.67--5.29-0.1117-0.11170.12640.105----------------16.40---84.48--0.2053-1.140.6527--------------
Auxly Cannabis Group Inc102.35m-60.27m62.53m369.00--0.6012--0.6109-0.0596-0.05960.10170.08320.34542.265.92277,374.00-20.34-21.47-30.18-24.997.935.08-58.89-124.150.3836-1.400.4399--6.99166.8565.84---40.92--
Data as of May 17 2024. Currency figures normalised to LSL Pharma Group Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.